RTW Biotech Opportunities (LON:RTW) Trading Down 0.7% – Here’s Why

RTW Biotech Opportunities (LON:RTWGet Free Report)’s stock price fell 0.7% during mid-day trading on Wednesday . The stock traded as low as GBX 1.52 ($0.02) and last traded at GBX 1.52 ($0.02). 11,510 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 510,035 shares. The stock had previously closed at GBX 1.53 ($0.02).

RTW Biotech Opportunities Price Performance

The business has a 50 day moving average of GBX 1.53 and a 200 day moving average of GBX 1.49. The firm has a market capitalization of £5.10 million, a price-to-earnings ratio of 4.22 and a beta of 0.60.

About RTW Biotech Opportunities

(Get Free Report)

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.

Featured Stories

Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.